Moderna (MRNA), once a pandemic-era darling, has seen its stock plummet 65% over the past year, battered by fading vaccine ...
4d
24/7 Wall St. on MSNCathie Wood Sours on Tesla and Moderna, but Likes These Stocks InsteadStar portfolio manager Cathie Wood’s Ark Investment Management filed its 13F holdings report for the fourth quarter on Feb. 4 ...
Goldman Sachs has ended a ban on underwriting companies with all-white, all-male boards, becoming the latest corporate giant ...
Goldman Sachs cancelled a four-year-old policy to only take public companies that had two diverse board members, a ...
Goldman Sachs would consider acquisitions in asset and wealth management, but would be highly selective about any deal, CEO ...
Plaid Inc., a financial technology firm best known for facilitating communication between startups and traditional banks, is ...
Goldman Sachs downgraded Dynavax to Sell, citing increased competition in the shingles vaccine market and uncertainty over hepatitis B revaccination demand.
Goldman Sachs Group Inc. is killing a significant pledge it made to refuse initial public offering business with companies ...
More than 60% of the S&P-listed companies have reported earnings, and the results are well above expectations. It’s safe to ...
Plaid, a company that connects bank accounts to financial applications, is working on a deal to allow early-stage investors and employees to sell their ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results